CERA

Science and Research

GATHER2: A Phase 3 Multicenter, Randomized, Double-Masked, Sham-controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients with Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Overview

  • Principal Investigator
Dr Thanh Nguyen